WO2007067054A1 - Emballage-coque à lignes de pliage - Google Patents

Emballage-coque à lignes de pliage Download PDF

Info

Publication number
WO2007067054A1
WO2007067054A1 PCT/NL2006/050306 NL2006050306W WO2007067054A1 WO 2007067054 A1 WO2007067054 A1 WO 2007067054A1 NL 2006050306 W NL2006050306 W NL 2006050306W WO 2007067054 A1 WO2007067054 A1 WO 2007067054A1
Authority
WO
WIPO (PCT)
Prior art keywords
blister pack
weakness
accommodation
connecting part
lines
Prior art date
Application number
PCT/NL2006/050306
Other languages
English (en)
Inventor
Patrick Antonius Hendrikus Meeren
Anouk Maria Louisa Meeren
Original Assignee
Meeren Patrick Antonius Hendri
Anouk Maria Louisa Meeren
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meeren Patrick Antonius Hendri, Anouk Maria Louisa Meeren filed Critical Meeren Patrick Antonius Hendri
Priority to US12/096,400 priority Critical patent/US20080302695A1/en
Priority to EP06824308A priority patent/EP1957378B1/fr
Publication of WO2007067054A1 publication Critical patent/WO2007067054A1/fr
Priority to HK09101256.8A priority patent/HK1120481A1/xx

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/04—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills
    • B65D83/0445—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments
    • B65D83/0463—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments formed in a band or a blisterweb, inserted in a dispensing device or container
    • B65D83/0472—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments formed in a band or a blisterweb, inserted in a dispensing device or container the band being wound in flat spiral, folded in accordion or the like
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
    • B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
    • B65D75/325—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil
    • B65D75/327—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil and forming several compartments
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/52—Details
    • B65D75/527—Tear-lines for separating a package into individual packages
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2585/00—Containers, packaging elements or packages specially adapted for particular articles or materials
    • B65D2585/56—Containers, packaging elements or packages specially adapted for particular articles or materials for medicinal tablets or pills

Definitions

  • the invention relates to a blister pack for dosage forms of a pharmaceutical formulation which is suitable for enteral administration, such as tablets, pills or capsules, comprising a plurality of accommodation units which are interconnected along lines of weakness, each accommodation unit being provided with a piercable base sheet and a cap part which is fixed to the base sheet, an accommodation space for accommodating an object being formed between the base sheet and the cap part of each accommodation unit.
  • Such a blister pack is known.
  • the blister pack forms a primary pack.
  • the packed dosage forms such as tablets, pills, capsules and the like, are also indicated below by the term objects. These objects are situated between the cap part and the base sheet.
  • the cap part can be deformed by heat, so that individual accommodation units are produced. Each accommodation unit is sufficiently large to contain the form of the individual object.
  • the cap part is closed off by the base sheet, which is fixed to the cap part.
  • This type of blister pack is sold in a container, such as a cardboard box, which surrounds the blister pack.
  • the container forms a secondary pack.
  • a disadvantage of this pack is, however, that because of the design of Hie blister pack described above, optimum use cannot be made of the available volume of the container, Le. the secondary pack. The latter contains a considerable empty space. Furthermore, the base sheet does not provide sufficient security, with the result that the contents can come out of it prematurely. This means that it is possible for the objects to come out of the pack accidentally.
  • the individual accommodation units are torn off the standard blister pack, sharp edges occur on the pack, so that the user can injure himself and/or can damage the environment, and in particular the base sheet of the pack.
  • the small mutual distance between the individual accommodation units makes them difficult to tear off. The result is that a number of adjacent base sheets of the individual accommodation units can be opened accidentally. Furthermore, the individual redistribution of the individual accommodation units, such as commonly occurs in institutions, is time-consuming and inefficient.
  • an object of the invention it to provide a blister pack which at least partially overcomes one or more of the abovementioned drawbacks.
  • This object is achieved according to the invention in that the blister pack comprises a plurality of connecting parts, each of which is connected by way of two respective lines of weakness to at least one accommodation unit in each case.
  • the blister pack according to the invention can be folded up along its lines of weakness.
  • the connecting parts which are provided between the accommodation units in such a way that they can be folded along the lines of weakness
  • the accommodation units can be placed, for example, alternately back to back against each other. This means that the space between the individual accommodation units is reduced, in other words the accommodation units of the folded blister pack according to the invention are packed more closely against each other. Since the volume taken up in the blister pack is then reduced, this produces a saving of space.
  • the empty space in the secondary pack which surrounds the blister pack according to the invention can be reduced.
  • the secondary pack can consequently contain a blister pack with more objects, or the secondary pack can be made smaller while accommodating a blister pack with the same number of objects.
  • the blister pack can, for example, contain ten pills or more, hi this case the connecting parts and the accommodation units connected to them can be aligned with each other in order to form an elongated, possibly folded strip.
  • Said strip therefore comprises a series of accommodation units and connecting parts, which are connected to each other by way of the lines of weakness.
  • the blister pack according to the invention it is also possible for the blister pack according to the invention to comprise a plurality of such series or strips which are interconnected parallel to and adjacent to each other along lines of weakness.
  • a further advantage of the blister pack according to the invention is that it means that less secondary packaging material is needed.
  • the primary packaging material is also reduced by reducing the contact surface between the individual accommodation units by using connecting parts, with the result that it is possible to provide the individual accommodation units with a maximum material-saving method, which is possibly based on the contents of the individual accommodation units.
  • the blister pack according to the invention prevents damage to the pack itself, injury to the user and damage to the environment of the pack, owing to the fact that the accommodation unit does not have any sharp comers.
  • Another advantage is that user convenience is increased by the fact of simply tearing along the lines of weakness of the individual accommodation units, since the mutual distance between the individual accommodation units is increased in pairs by the mutual connecting parts. This gives users more space to press the individual contents per accommodation unit out of the primary pack through base sheet, which reduces the risk of accidentally pressing out several accommodation units.
  • Another advantage is more efficient redistribution of the individual accommodation units by the fact that the connecting parts make it possible to wind the primary packaging material onto a core body, so mat large quantities of individual accommodation units can be supplied on a roll.
  • a pharmaceutical pack is disclosed in US3659706.
  • This pack has a pair of blister sheets which are interconnected by a hinge part
  • the blister sheets can be folded along the hinge part, so that the blister sheets lie above one another.
  • the cap parts of the blister sheets are accommodated inside each other after folding.
  • This pack is not, however, provided with a plurality of connecting parts, so that the accommodation units of the blister sheets cannot be individually folded.
  • the base sheet of this blister pack faces outwards, which increases the risk of damage.
  • a pack is disclosed in GB 2096574.
  • This pack comprises a transparent cover which is fixed to a cardboard base sheet A bottle is accommodated between the two.
  • a plurality of these packs can be connected to each other by way of perforation lines.
  • a spacer is provided between two pairs of interconnected packs. This makes it possible to fold up the packs.
  • this pack does not relate to dosage forms of a pharmaceutical formulation which is suitable for enteral administration.
  • the lines of weakness of the connecting part to be situated on either side of said connecting part. In this case the lines of weakness are provided on opposite edges of the connecting part. The lines of weakness extend substantially parallel to each other.
  • the connecting part or each connecting part prefferably be connected by way of each line of weakness thereof to a pair of accommodation units which are directly connected to each other by way of a line of weakness.
  • two accommodation units in each case are directly connected to each other along a line of weakness, which two accommodation units form a pair.
  • a connecting part is provided in each case between said pairs of accommodation units, which connecting part is connected by way of lines of weakness to each pair.
  • each accommodation unit prefferably be of a height which is determined by the distance running substantially perpendicularly relative to the base sheet from the base sheet to the top of the cap part, and for the connecting part to be of a length which is determined by the distance between its lines of weakness, and for the length of the connecting part to be substantially greater than or equal to the height of an accommodation unit
  • the lines of weakness of a connecting part are the lines of weakness by means of which said connecting part is connected to one or two accommodation units in each case.
  • the length of the connecting part is at least equal to substantially twice the height of an accommodation unit. If the ratio of said length and said height is substantially equal to two, the blister pack can be folded up in zigzag fashion to a particularly compact size.
  • the length of the connecting parts can, however, also be greater than twice the height of the accommodation units.
  • each accommodation unit prefferably be of a length which is determined by the distance between the lines of weakness by means of which said accommodation unit is connected to a connecting part and/or further accommodation unit, and for the length of the connecting part to be substantially less than the length of the accommodation unit.
  • the lines of weakness of an accommodation unit are the lines of weakness by means of which said accommodation unit is connected to a connecting part or a further accommodation unit in each case.
  • each accommodation unit and each connecting part is of a respective width which in each case is determined by its maximum distance in the direction running substantially parallel to the lines of weakness, and the width of the connecting part is less than the width of an accommodation unit.
  • the connecting parts are then narrower than the accommodation units.
  • each accommodation unit substantially corresponds to the circumference of the object accommodated in it. If the blister pack according to the invention is filled with, for example, disc-shaped pills, which are substantially round, it is preferable for each accommodation unit also to be of a round shape.
  • the blister pack can comprise various materials.
  • the base sheet of the accommodation units is made of aluminium
  • the cap part of the accommodation units is made of plastic, such as polyvinyl chloride (PVC) or polyethylene terephthalate (PET).
  • PVC polyvinyl chloride
  • PET polyethylene terephthalate
  • the base sheet and/or the cap part can, however, also comprise other materials.
  • amorphous polyamide PA
  • polyethylene naphthalate PEN
  • PCTFE polychlorotrifluoroethylene
  • PVC polyvinyl chloride
  • PVDC polyvinylidene chloride
  • PP polypropylene
  • COC cyclo-olefin copolymer
  • LCP liquid crystal polymer
  • EVOH ethylene vinyl alcohol
  • PVOH polyvinyl alcohol
  • PAN polyacrylonitrile
  • PS polystyrene
  • biaxially oriented polyamide OPA
  • chlorotrifluoroethyelene CTFE
  • HDPE high-density polyethylene
  • LDPE low- density polyethylene
  • the base sheet and/or the cap part can also be made of, for example, any combination of the abovementioned materials.
  • the invention also relates to an assembly of a blister pack of the type described above and a container in which said blister pack is accommodated. It is possible here for the blister pack to be folded up in zigzag fashion and for the dimensions of the container to correspond substantially to the dimensions of the folded blister pack. The blister pack folded up in zigzag fashion is then accommodated in a close fit in the container, for example a box. The pack formed by the assembly is compact.
  • the invention furthermore relates to a method for packaging objects such as tablets, pills or capsules, comprising the provision of a blister pack of the type described above and folding up the blister pack, preferably in zigzag fashion, along the lines of weakness.
  • Figures IA-D show four side views of a blister pack according to a first embodiment, folded up substantially in zigzag fashion, the opening out of two accommodation units being shown in four steps;
  • Figures 2A-D show four top views of the embodiment shown in Figures IA-D;
  • Figures 3A-D show four top views of a blister pack according to a second embodiment, folded up substantially in zigzag fashion, the opening out of two pairs of accommodation units being shown in four steps;
  • Figure 4 A shows an elevational view in cross section of an accommodation unit of the embodiments shown in Figures 1 and 2;
  • Figures 4B-C show a top view and side view of the accommodation unit shown in Figure 4A;
  • Figure 5 shows a side view of a blister pack in a folded state
  • Figure 6 shows a side view of the blister pack shown in Figure 5 in a semi-folded state
  • Figure 7 shows a side view of the blister pack shown in Figure 5 in a substantially fully opened-out state
  • Figures 8A-D show four top views of four different embodiments of connecting parts of a blister pack respectively;
  • Figure 9 shows an enlarged top view of an accommodation unit and a connecting part
  • Figure 10 shows two side views of a blister pack, in which the length of the connecting part is twice the height of the accommodation unit;
  • Figures 1 IA, B are views of a blister pack which can be rolled up around a core body
  • Figure 12 shows a side view of a further embodiment of a blister pack in a folded state
  • Figure 13 shows a side view of the embodiment shown in Figure 12, in an opened-out state.
  • the embodiment of the blister pack shown in Figures 1 and 2 comprises a strip of ten accommodation units 1.
  • the number of accommodation units can, of course, be different.
  • the accommodation units 1 form a single row.
  • the blister pack has several pairs of accommodation units directly connected to each other.
  • a line of weakness 2 is situated between each pair of accommodation units 1.
  • the blister pack comprises a number of connecting parts 3— in this exemplary embodiment four connecting parts 3.
  • the connecting parts 3 are provided between two pairs of accommodation units 1 in each case.
  • the connecting parts 3 are connected by means of lines of weakness 2 to the adjacent accommodation units 1.
  • the blister pack can be folded up in zigzag fashion along the lines of weakness to the state shown in Figure IA. From the folded state the accommodation units can be opened out or deployed, as shown in Figures IB-D.
  • Figures IA and IB furthermore show diagrammatically by dashed and dotted lines a container in which the blister pack can be accommodated.
  • the blister pack forms a primary pack
  • the container forms a secondary pack.
  • the dimensions of the container are adapted to the dimensions of the blister pack in the folded state. Between the inside of the container and the folded blister pack there is only a relatively small amount of play.
  • the container can be in different forms.
  • the container is in the form of a cardboard box with a lip on one end face or on both end faces. The lip can be opened out to reach the blister pack.
  • the blister pack according to the invention can be adapted to this. This means that no accommodation units remain unused, as regularly occurs in the case of known pharmaceutical blister packs.
  • the embodiment shown in Figure 3 comprises two parallel strips of accommodation units 1.
  • the strips form two adjacent rows of accommodation units 1.
  • the accommodation units 1 of each strip are connected to each other in pairs by one connecting part 3 in each case.
  • Each connecting part 3 is connected by way of two opposite lines of weakness 2 to two accommodation units 1 in each case, which accommodation units are directly connected to each other by way of a line of weakness
  • accommodation units 1 are fixed to each other at laterally adjacent accommodation units 1 thereof in each case.
  • this exemplary embodiment comprises two strips of ten accommodation units 1, i.e. a total of twenty accommodation units 1, said double blister pack can, of course, comprise more or fewer accommodation units 1.
  • the accommodation units 1 of the embodiments shown in Figures 1 and 2 each comprise a piercable base sheet or bottom sheet 5 and a cap part 4, which is fixed to the base sheet 5 (see Figure 4A).
  • the cap part 4 of each accommodation unit 1 has a circumferential edge which is aligned relative to the piercable base sheet 5 (see also Figures 4B and 4C).
  • the cap part 4 and the base sheet 5 bound an interior accommodation space 7.
  • the accommodation space 7 contains a dosage form 6 of a pharmaceutical formulation which is suitable for enteral or oral administration, such as tablets, pills or capsules.
  • the dosage forms 6 form objects packed in the blister pack.
  • Figure 4A shows furthermore that the connecting part 3 can have a further line of weakness 2 ⁇
  • the line of weakness 2' is, for example, provided centrally between the lines of weakness 2 by means of which the connecting part 3 is connected to the adjacent accommodation units 1.
  • the further line of weakness 2' reduces the risk of the base sheet 5 tearing when an accommodation unit 1 is removed from the blister pack.
  • Said blister pack can comprise one strip or two or more laterally connected strips of accommodation units 1.
  • the strip or strips in Figures 5 - 7 comprise six accommodation units, the number of accommodation units 1 can differ from this number.
  • the accommodation units 1 are connected to each other in pairs in each case by a connecting part 3, which is provided with lines of weakness 2.
  • Each accommodation unit 1 is connected on either side of said unit by way of a line of weakness 2 in each case to a connecting part 3 and a further accommodation unit 1 respectively.
  • the connecting part 3 can be designed in various ways according to the invention.
  • the connecting part is formed as shown in Figures 8A-D.
  • the connecting parts 3, 103, 203, 303 are provided between two pairs of accommodation units 1.
  • the connecting parts 3, 103, 203, 303 are connected by way of lines of weakness 2 to said pairs of accommodation units 1.
  • the accommodation units 1 according to the invention can be of a round shape.
  • the line of weakness between the accommodation unit 1 and the connecting part 3 is preferably straight, but it can also correspond to the round shape of the accommodation unit (see Figure 9).
  • the cap part 4 is connected to the piercable base sheet 5 for the purpose of protecting the enclosed object 6. There may be play between the object 6 and the cap part 4 and/or base sheet 5.
  • the length L of the connecting part 3 is twice the height H of the accommodation units 1.
  • the accommodation units 1 are connected to each other in pairs by way of the lines of weakness 2, with the interposition of a connecting element 3 in each case.
  • the accommodation units 1 of each pair are likewise connected to each other by way of a line of weakness 2. Adapting the length L of the connecting parts 3 and the height H of the accommodation units 1 of the blister pack to each other makes the blister pack particularly compact in the folded state.
  • the strip of accommodation units 1 and connecting parts 3 which are connected by lines of weakness 2 is rolled up in a direction 9 around a core body 8.
  • one strip or a plurality of strips of accommodation units 1 laterally connected to each other can be rolled up on the core body 8.
  • said rolled-up strip or strips of accommodation units not to have any connecting parts 3, i.e. the accommodation units in this case are connected to each other only by way of lines of weakness.
  • FIGs 12 and 13 Said blister pack can be folded up in zigzag fashion along the lines of weakness 2, the base sheets 5 resting against the cap parts 4.
  • the blister pack is shown opened out in Figure 13.
  • a connecting part 3 is situated between each pair of adjacent accommodation units 1, which connecting part is connected by way of lines of weakness 2 to said accommodation units 1.
  • the cap parts 4 of adjacent accommodation units 1 lie on either side of the base sheet 5.
  • the length of the connecting parts 3 in this exemplary embodiment is substantially equal to the height of the accommodation units 1.
  • the invention is not limited by the exemplary embodiments shown in the figures, which the person skilled in the art can adapt in various ways.
  • the number of accommodation units 1 of the blister pack according to the invention can be extended by adding further strips of accommodation units 1 and connecting parts 3 and/or extending one or more strips by adding further accommodation units 1 and connecting parts 3. It is also possible according to the invention for more than one or two accommodation units 1 to be provided between two connecting parts 3 of a strip. It is even possible for the number of accommodation units 1 between two connecting parts 3 in a strip of accommodation units 1 and connecting parts 1 to vary.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • Composite Materials (AREA)
  • Packages (AREA)

Abstract

La présente invention concerne un emballage-coque pour des objets, tels que comprimés, pilules ou capsules, comprenant une pluralité d’unités de logement (1) interconnectées le long de lignes de moindre résistance (2). Chaque unité de logement (1) est dotée d’une feuille de base perçable (5) et d’une partie d’opercule (4) fixée à la feuille de base (5). Un espace de logement (7) servant à loger un objet (6) est formé entre la feuille de base et la partie d’opercule pour chaque unité de logement. L’emballage-coque comprend une pluralité de partie de raccord (3), chacune étant reliée au moyen de deux lignes respectives de moindre résistance (2) à au moins une unité de logement dans chaque cas.
PCT/NL2006/050306 2005-12-06 2006-12-06 Emballage-coque à lignes de pliage WO2007067054A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US12/096,400 US20080302695A1 (en) 2005-12-06 2006-12-06 Blister Pack with Fold Lines
EP06824308A EP1957378B1 (fr) 2005-12-06 2006-12-06 Emballage-coque à lignes de pliage
HK09101256.8A HK1120481A1 (en) 2005-12-06 2009-02-11 Blister pack with fold lines

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1030608A NL1030608C2 (nl) 2005-12-06 2005-12-06 Blisterverpakking, samenstel van een blisterverpakking en een houder, alsmede werkwijze voor het verpakken van objecten.
NL1030608 2005-12-06

Publications (1)

Publication Number Publication Date
WO2007067054A1 true WO2007067054A1 (fr) 2007-06-14

Family

ID=37757090

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL2006/050306 WO2007067054A1 (fr) 2005-12-06 2006-12-06 Emballage-coque à lignes de pliage

Country Status (5)

Country Link
US (1) US20080302695A1 (fr)
EP (1) EP1957378B1 (fr)
HK (1) HK1120481A1 (fr)
NL (1) NL1030608C2 (fr)
WO (1) WO2007067054A1 (fr)

Cited By (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008114177A1 (fr) * 2007-03-16 2008-09-25 Mechatronic Engineering S.R.L. Conditionnement pour pilules, bonbons et similaires
WO2011113439A1 (fr) * 2010-03-18 2011-09-22 Futurelogix Aps Récipient rigide jetable pour compositions pharmaceutiques
WO2013070914A3 (fr) * 2011-11-09 2013-08-08 Proteus Digital Health, Inc. Appareil, système, et procédé permettant de gérer une adhésion à un régime
US8542123B2 (en) 2008-03-05 2013-09-24 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8540632B2 (en) 2007-05-24 2013-09-24 Proteus Digital Health, Inc. Low profile antenna for in body device
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US8540633B2 (en) 2008-08-13 2013-09-24 Proteus Digital Health, Inc. Identifier circuits for generating unique identifiable indicators and techniques for producing same
US8547248B2 (en) 2005-09-01 2013-10-01 Proteus Digital Health, Inc. Implantable zero-wire communications system
US8545402B2 (en) 2009-04-28 2013-10-01 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US8558563B2 (en) 2009-08-21 2013-10-15 Proteus Digital Health, Inc. Apparatus and method for measuring biochemical parameters
US8597186B2 (en) 2009-01-06 2013-12-03 Proteus Digital Health, Inc. Pharmaceutical dosages delivery system
US8674825B2 (en) 2005-04-28 2014-03-18 Proteus Digital Health, Inc. Pharma-informatics system
US8718193B2 (en) 2006-11-20 2014-05-06 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US8784308B2 (en) 2009-12-02 2014-07-22 Proteus Digital Health, Inc. Integrated ingestible event marker system with pharmaceutical product
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8858432B2 (en) 2007-02-01 2014-10-14 Proteus Digital Health, Inc. Ingestible event marker systems
US8868453B2 (en) 2009-11-04 2014-10-21 Proteus Digital Health, Inc. System for supply chain management
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8932221B2 (en) 2007-03-09 2015-01-13 Proteus Digital Health, Inc. In-body device having a multi-directional transmitter
US8945005B2 (en) 2006-10-25 2015-02-03 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US8956287B2 (en) 2006-05-02 2015-02-17 Proteus Digital Health, Inc. Patient customized therapeutic regimens
US8956288B2 (en) 2007-02-14 2015-02-17 Proteus Digital Health, Inc. In-body power source having high surface area electrode
US8961412B2 (en) 2007-09-25 2015-02-24 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US9107806B2 (en) 2010-11-22 2015-08-18 Proteus Digital Health, Inc. Ingestible device with pharmaceutical product
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US9268909B2 (en) 2012-10-18 2016-02-23 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
US9271897B2 (en) 2012-07-23 2016-03-01 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
US9597487B2 (en) 2010-04-07 2017-03-21 Proteus Digital Health, Inc. Miniature ingestible device
US9603550B2 (en) 2008-07-08 2017-03-28 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US9883819B2 (en) 2009-01-06 2018-02-06 Proteus Digital Health, Inc. Ingestion-related biofeedback and personalized medical therapy method and system
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US10187121B2 (en) 2016-07-22 2019-01-22 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US10223905B2 (en) 2011-07-21 2019-03-05 Proteus Digital Health, Inc. Mobile device and system for detection and communication of information received from an ingestible device
WO2019081526A2 (fr) 2017-10-26 2019-05-02 Unilever Plc Emballage pour produit
WO2019081527A2 (fr) 2017-10-26 2019-05-02 Unilever Plc Emballage de produit
WO2019081528A1 (fr) * 2017-10-26 2019-05-02 Unilever Plc Emballage de produit
US10398161B2 (en) 2014-01-21 2019-09-03 Proteus Digital Heal Th, Inc. Masticable ingestible product and communication system therefor
US10529044B2 (en) 2010-05-19 2020-01-07 Proteus Digital Health, Inc. Tracking and delivery confirmation of pharmaceutical products
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US11149123B2 (en) 2013-01-29 2021-10-19 Otsuka Pharmaceutical Co., Ltd. Highly-swellable polymeric films and compositions comprising the same
US11529071B2 (en) 2016-10-26 2022-12-20 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
US11612321B2 (en) 2007-11-27 2023-03-28 Otsuka Pharmaceutical Co., Ltd. Transbody communication systems employing communication channels
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110005961A1 (en) * 2008-02-28 2011-01-13 Ludovic Leplatois Extrusion-Coated Lidding Foil For Push-Through Blister Packaging
USD594348S1 (en) 2008-06-24 2009-06-16 Colgate-Palmolive Company Multiple product package
WO2010004566A1 (fr) * 2008-07-10 2010-01-14 2P2D Solutions Ltd Dispositif de distribution de médicament et procédé d’utilisation de celui-ci
ES2429819T3 (es) 2009-03-16 2013-11-18 Colgate-Palmolive Company Envase de presentación
TWI401189B (zh) * 2009-09-18 2013-07-11 Colgate Palmolive Co 用於產品之展示包裝盒
US8479921B2 (en) 2009-12-09 2013-07-09 Amcor Flexibles, Inc. Child resistant blister package
EP2353573B1 (fr) 2010-02-10 2012-08-22 E-Pharma Trento S.p.A. Nouvel emballage coque renforcé
US20120145585A1 (en) 2010-12-08 2012-06-14 Id-Con, Llc Packaging systems and methods
BR112013019410A2 (pt) * 2011-02-04 2019-09-24 Taris Biomedical Inc dispositivo implantável para liberação controlada de fármaco de solubilidade baixa
WO2013013108A2 (fr) 2011-07-19 2013-01-24 Id-Con, Llc Systèmes et procédés d'emballage
WO2013128459A1 (fr) * 2012-03-01 2013-09-06 2P2D Solutions Ltd. Chaîne blister repliée, machine de pliage et procédé de pliage
KR101483482B1 (ko) * 2013-12-10 2015-01-29 주식회사 블리스팩 개선된 시각성을 갖는 블리스터 포장체
CN107427408A (zh) 2015-01-21 2017-12-01 迈兰公司 药物包装和剂量方案系统
CN109573324A (zh) * 2019-01-16 2019-04-05 叶卫东 一次性补充液包装瓶
CN112849492A (zh) * 2021-01-14 2021-05-28 王骏桃 一种新型片状滤袋固体饮料的包装方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1127554A (fr) * 1955-06-04 1956-12-19 Vitrine en relief
US3659706A (en) 1970-04-24 1972-05-02 Parke Davis & Co Pharmacal package construction
GB2096574A (en) 1981-04-10 1982-10-20 Fraser Chemicals Nottingham Lt Package assemblies
WO2000030189A1 (fr) * 1998-11-18 2000-05-25 Eveready Battery Company, Inc. Distributeur de bande de piles
US20030075561A1 (en) * 2001-10-18 2003-04-24 Pieri Kenneth H. Toothpaste dispenser

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2771214A (en) * 1953-09-14 1956-11-20 Ivers Lee Co Dispensing carton for package strips
DE2322055A1 (de) * 1973-05-02 1975-01-30 Bosch Gmbh Robert Kindersichere tablettenpackung
US5046618A (en) * 1990-11-19 1991-09-10 R. P. Scherer Corporation Child-resistant blister pack
SE9502370D0 (sv) * 1995-06-30 1995-06-30 Astra Ab Blister pack, especially for drugs, as well as method and device in manufacturing the same
SE515129C2 (sv) * 1996-07-01 2001-06-11 Astrazeneca Ab Blisterförpackning, apparat och förfarande för tillverkning av en blisterförpackning samt användning av en blisterförpackning
US5957358A (en) * 1997-11-14 1999-09-28 Eveready Battery Company, Inc. Battery strip dispenser
US6273260B1 (en) * 2000-03-08 2001-08-14 Eli Lilly And Company Pharmaceutical packaging system

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1127554A (fr) * 1955-06-04 1956-12-19 Vitrine en relief
US3659706A (en) 1970-04-24 1972-05-02 Parke Davis & Co Pharmacal package construction
GB2096574A (en) 1981-04-10 1982-10-20 Fraser Chemicals Nottingham Lt Package assemblies
WO2000030189A1 (fr) * 1998-11-18 2000-05-25 Eveready Battery Company, Inc. Distributeur de bande de piles
US20030075561A1 (en) * 2001-10-18 2003-04-24 Pieri Kenneth H. Toothpaste dispenser

Cited By (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8847766B2 (en) 2005-04-28 2014-09-30 Proteus Digital Health, Inc. Pharma-informatics system
US8674825B2 (en) 2005-04-28 2014-03-18 Proteus Digital Health, Inc. Pharma-informatics system
US9649066B2 (en) 2005-04-28 2017-05-16 Proteus Digital Health, Inc. Communication system with partial power source
US9161707B2 (en) 2005-04-28 2015-10-20 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US10610128B2 (en) 2005-04-28 2020-04-07 Proteus Digital Health, Inc. Pharma-informatics system
US10542909B2 (en) 2005-04-28 2020-01-28 Proteus Digital Health, Inc. Communication system with partial power source
US10517507B2 (en) 2005-04-28 2019-12-31 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US8816847B2 (en) 2005-04-28 2014-08-26 Proteus Digital Health, Inc. Communication system with partial power source
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US9962107B2 (en) 2005-04-28 2018-05-08 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US9681842B2 (en) 2005-04-28 2017-06-20 Proteus Digital Health, Inc. Pharma-informatics system
US9119554B2 (en) 2005-04-28 2015-09-01 Proteus Digital Health, Inc. Pharma-informatics system
US9439582B2 (en) 2005-04-28 2016-09-13 Proteus Digital Health, Inc. Communication system with remote activation
US11476952B2 (en) 2005-04-28 2022-10-18 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US8547248B2 (en) 2005-09-01 2013-10-01 Proteus Digital Health, Inc. Implantable zero-wire communications system
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8956287B2 (en) 2006-05-02 2015-02-17 Proteus Digital Health, Inc. Patient customized therapeutic regimens
US11928614B2 (en) 2006-05-02 2024-03-12 Otsuka Pharmaceutical Co., Ltd. Patient customized therapeutic regimens
US10238604B2 (en) 2006-10-25 2019-03-26 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US8945005B2 (en) 2006-10-25 2015-02-03 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US11357730B2 (en) 2006-10-25 2022-06-14 Otsuka Pharmaceutical Co., Ltd. Controlled activation ingestible identifier
US9444503B2 (en) 2006-11-20 2016-09-13 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US9083589B2 (en) 2006-11-20 2015-07-14 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US8718193B2 (en) 2006-11-20 2014-05-06 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US10441194B2 (en) 2007-02-01 2019-10-15 Proteus Digital Heal Th, Inc. Ingestible event marker systems
US8858432B2 (en) 2007-02-01 2014-10-14 Proteus Digital Health, Inc. Ingestible event marker systems
US8956288B2 (en) 2007-02-14 2015-02-17 Proteus Digital Health, Inc. In-body power source having high surface area electrode
US11464423B2 (en) 2007-02-14 2022-10-11 Otsuka Pharmaceutical Co., Ltd. In-body power source having high surface area electrode
US8932221B2 (en) 2007-03-09 2015-01-13 Proteus Digital Health, Inc. In-body device having a multi-directional transmitter
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
WO2008114177A1 (fr) * 2007-03-16 2008-09-25 Mechatronic Engineering S.R.L. Conditionnement pour pilules, bonbons et similaires
US8540632B2 (en) 2007-05-24 2013-09-24 Proteus Digital Health, Inc. Low profile antenna for in body device
US10517506B2 (en) 2007-05-24 2019-12-31 Proteus Digital Health, Inc. Low profile antenna for in body device
US8961412B2 (en) 2007-09-25 2015-02-24 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US9433371B2 (en) 2007-09-25 2016-09-06 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US11612321B2 (en) 2007-11-27 2023-03-28 Otsuka Pharmaceutical Co., Ltd. Transbody communication systems employing communication channels
US9060708B2 (en) 2008-03-05 2015-06-23 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8542123B2 (en) 2008-03-05 2013-09-24 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8810409B2 (en) 2008-03-05 2014-08-19 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US9258035B2 (en) 2008-03-05 2016-02-09 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US10682071B2 (en) 2008-07-08 2020-06-16 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US11217342B2 (en) 2008-07-08 2022-01-04 Otsuka Pharmaceutical Co., Ltd. Ingestible event marker data framework
US9603550B2 (en) 2008-07-08 2017-03-28 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US8721540B2 (en) 2008-08-13 2014-05-13 Proteus Digital Health, Inc. Ingestible circuitry
US9415010B2 (en) 2008-08-13 2016-08-16 Proteus Digital Health, Inc. Ingestible circuitry
US8540633B2 (en) 2008-08-13 2013-09-24 Proteus Digital Health, Inc. Identifier circuits for generating unique identifiable indicators and techniques for producing same
US9883819B2 (en) 2009-01-06 2018-02-06 Proteus Digital Health, Inc. Ingestion-related biofeedback and personalized medical therapy method and system
US8597186B2 (en) 2009-01-06 2013-12-03 Proteus Digital Health, Inc. Pharmaceutical dosages delivery system
US9119918B2 (en) 2009-03-25 2015-09-01 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US8545402B2 (en) 2009-04-28 2013-10-01 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US9320455B2 (en) 2009-04-28 2016-04-26 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US10588544B2 (en) 2009-04-28 2020-03-17 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
US8558563B2 (en) 2009-08-21 2013-10-15 Proteus Digital Health, Inc. Apparatus and method for measuring biochemical parameters
US8868453B2 (en) 2009-11-04 2014-10-21 Proteus Digital Health, Inc. System for supply chain management
US10305544B2 (en) 2009-11-04 2019-05-28 Proteus Digital Health, Inc. System for supply chain management
US9941931B2 (en) 2009-11-04 2018-04-10 Proteus Digital Health, Inc. System for supply chain management
US8784308B2 (en) 2009-12-02 2014-07-22 Proteus Digital Health, Inc. Integrated ingestible event marker system with pharmaceutical product
EA021081B1 (ru) * 2010-03-18 2015-03-31 Медкомб Холдинг Апс Одноразовая медицинская упаковка для фармацевтических композиций и способ ее изготовления
CN103002854B (zh) * 2010-03-18 2015-01-21 麦德康股份有限公司 用于药物组合物的一次性刚性容器
CN103002854A (zh) * 2010-03-18 2013-03-27 麦德康股份有限公司 用于药物组合物的一次性刚性容器
WO2011113439A1 (fr) * 2010-03-18 2011-09-22 Futurelogix Aps Récipient rigide jetable pour compositions pharmaceutiques
US8459458B2 (en) 2010-03-18 2013-06-11 Medcomb Holding Aps Disposable rigid container for pharmaceutical compositions
US10207093B2 (en) 2010-04-07 2019-02-19 Proteus Digital Health, Inc. Miniature ingestible device
US9597487B2 (en) 2010-04-07 2017-03-21 Proteus Digital Health, Inc. Miniature ingestible device
US11173290B2 (en) 2010-04-07 2021-11-16 Otsuka Pharmaceutical Co., Ltd. Miniature ingestible device
US10529044B2 (en) 2010-05-19 2020-01-07 Proteus Digital Health, Inc. Tracking and delivery confirmation of pharmaceutical products
US9107806B2 (en) 2010-11-22 2015-08-18 Proteus Digital Health, Inc. Ingestible device with pharmaceutical product
US11504511B2 (en) 2010-11-22 2022-11-22 Otsuka Pharmaceutical Co., Ltd. Ingestible device with pharmaceutical product
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US11229378B2 (en) 2011-07-11 2022-01-25 Otsuka Pharmaceutical Co., Ltd. Communication system with enhanced partial power source and method of manufacturing same
US10223905B2 (en) 2011-07-21 2019-03-05 Proteus Digital Health, Inc. Mobile device and system for detection and communication of information received from an ingestible device
WO2013070914A3 (fr) * 2011-11-09 2013-08-08 Proteus Digital Health, Inc. Appareil, système, et procédé permettant de gérer une adhésion à un régime
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
US9271897B2 (en) 2012-07-23 2016-03-01 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
US9268909B2 (en) 2012-10-18 2016-02-23 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
US11149123B2 (en) 2013-01-29 2021-10-19 Otsuka Pharmaceutical Co., Ltd. Highly-swellable polymeric films and compositions comprising the same
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10421658B2 (en) 2013-08-30 2019-09-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11950615B2 (en) 2014-01-21 2024-04-09 Otsuka Pharmaceutical Co., Ltd. Masticable ingestible product and communication system therefor
US10398161B2 (en) 2014-01-21 2019-09-03 Proteus Digital Heal Th, Inc. Masticable ingestible product and communication system therefor
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US10797758B2 (en) 2016-07-22 2020-10-06 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US10187121B2 (en) 2016-07-22 2019-01-22 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US11529071B2 (en) 2016-10-26 2022-12-20 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
US11793419B2 (en) 2016-10-26 2023-10-24 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
WO2019081527A3 (fr) * 2017-10-26 2019-07-11 Unilever Plc Emballage de produit
WO2019081526A3 (fr) * 2017-10-26 2019-07-11 Unilever Plc Emballage pour produit
WO2019081528A1 (fr) * 2017-10-26 2019-05-02 Unilever Plc Emballage de produit
US11708203B2 (en) 2017-10-26 2023-07-25 Conopco, Inc. Product packaging
WO2019081527A2 (fr) 2017-10-26 2019-05-02 Unilever Plc Emballage de produit
WO2019081526A2 (fr) 2017-10-26 2019-05-02 Unilever Plc Emballage pour produit

Also Published As

Publication number Publication date
US20080302695A1 (en) 2008-12-11
EP1957378B1 (fr) 2012-08-22
NL1030608C2 (nl) 2007-06-07
HK1120481A1 (en) 2009-04-03
EP1957378A1 (fr) 2008-08-20

Similar Documents

Publication Publication Date Title
EP1957378B1 (fr) Emballage-coque à lignes de pliage
US6253920B1 (en) Blister pack
US7631764B2 (en) Package for a personal care product
KR100408580B1 (ko) 콘택트렌즈용나열형포장용기및이를수용하기위한복합포장재
JP4446745B2 (ja) 薬剤治療ブリスターカード
US20030006163A1 (en) Childproof blister packaging
CA2491007A1 (fr) Conditionnement pour distribution de portions individuelles
JP2004502611A (ja) キー穴形状開口部を有する単位投与量ブリスタ包装
EP2353573B1 (fr) Nouvel emballage coque renforcé
MX2011002370A (es) Envase de dosis unitaria a prueba de niños para sistemas terapeuticos transdermicos o formas de dosificacion de tipo pelicula o de tipo lamina.
NO338848B1 (no) Filmbeholder
CN103189280A (zh) 用于携带物品的儿童防护盒子和坯件
CN112074468A (zh) 卫生薄页纸包装体
USRE37558E1 (en) Packaging arrangement for contact lenses
US20110233267A1 (en) Pack having tear-open aid
RU2802709C2 (ru) Упаковка, защищенная от детей
JP3215140U (ja) 紙おむつ配送箱
JP2002531333A (ja) 少なくとも２種の異なる一次パックのための折りたたみ箱組み合わせの形態の薬物用の包装手段
US11866240B2 (en) Child-resistant packaging
CN217375628U (zh) 铝塑泡罩板包装盒
CA2197786C (fr) Plaquette alveolaire
OA20511A (en) Child-resistant packaging
GB2400600A (en) Separator for a sandwich pack

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2006824308

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 1219/MUMNP/2008

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 12096400

Country of ref document: US